Caribou Biosciences, Inc.
CRBU- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001619856
No open-market purchases or sales by Caribou Biosciences, Inc. insiders were filed in the last 90 days; 137 institutions reported holding it in 13F filings for Q2 2026, worth $84.8M in total; Maverick Capital is the only superinvestor holding it.
Q3 2025 vs. Q2 2025
How the institutions holding Caribou Biosciences, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 129 | 117 | −12 |
| Shares | 40.8M | 37.2M | −3.61M (−8.8%) |
| Value | $51.2M | $87.0M | +$35.8M (+69.9%) |
New holders (16)
Institutions that held Caribou Biosciences, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Graham Capital Management, L.P. | 128,352 | $299.1K | 0.01% |
| Marshall Wace, LLP | 125,844 | $293.2K | 0.00% |
| American Century Companies Inc | 81,802 | $190.6K | 0.00% |
| Jefferies Financial Group Inc. | 47,200 | $110.0K | 0.00% |
| Qube Research & Technologies Ltd | 45,150 | $105.2K | 0.00% |
| Susquehanna Portfolio Strategies, LLC | 29,883 | $69.6K | 0.00% |
| Credit Agricole S A | 29,000 | $67.6K | 0.00% |
| Simplex Trading, LLC | 21,123 | $49.0K | 0.00% |
| Liberty Wealth Management LLC | 19,500 | $45.4K | 0.01% |
| R Squared Ltd | 12,268 | $28.6K | 0.01% |
| LPL Financial LLC | 10,296 | $24.0K | 0.00% |
| Wealthspire Advisors, LLC | 7,500 | $17.5K | 0.00% |
| Atlantic Union Bankshares Corp | 3,200 | $7.46K | 0.00% |
| Advisory Services Network, LLC | 914 | $2.13K | 0.00% |
| SRS Capital Advisors, Inc. | 506 | $1.18K | 0.00% |
| Sunbelt Securities, Inc. | 135 | $315 | 0.00% |
Sold out (28)
Institutions that held Caribou Biosciences, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.